By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MabVax Therapeutics, Inc. 

11588 Sorrento Valley Road
Suite 20
San Diego  California  92121  U.S.A
Phone: 858-259-9405 Fax:



Company News
MabVax Therapeutics, Inc. Completes Manufacturing Of HuMab 5B1 for Upcoming Phase I Clinical Trials 11/3/2015 6:15:54 AM
MabVax Therapeutics, Inc. HuMab 5B1 Antibody Featured In Five Presentations At The World Molecular Imaging Congress 10/21/2015 10:15:34 AM
MabVax Therapeutics, Inc. To Hold Investor Webcast And Conference Call On Thursday, October 22nd At 11:00 Am EDT 10/20/2015 11:43:22 AM
MabVax Therapeutics, Inc. HuMab 5B1 Antibody Is Highlighted At Upcoming World Molecular Imaging Congress In Five Separate Presentations 8/31/2015 8:56:02 AM
MabVax Therapeutics, Inc. And The Rockefeller University Enter Into A Collaborative Research Agreement 8/6/2015 6:35:16 AM
MabVax Therapeutics, Inc. Issues Letter To Stockholders 8/5/2015 7:13:02 AM
MabVax Therapeutics Holdings To Present At The 2015 LD Micro Invitational Investor Conference On June 2nd At 4:30 PM EDT 5/28/2015 7:48:33 AM
MabVax Therapeutics, Inc.' Human Antibody Clinical Development Candidate HuMab 5B1 Successfully Clears Important Early Toxicology Testing 5/5/2015 6:28:22 AM
MabVax Therapeutics, Inc. Appoints Tom Varvaro To Its Board Of Directors 4/7/2015 9:45:01 AM
MabVax Therapeutics, Inc. Announces Closing Of Financing 4/6/2015 8:00:52 AM